When does the apremilast patent expire?
Apremilast (Otezla) is protected by multiple patents, so “the” expiration date depends on which specific patent or market exclusivity you mean. DrugPatentWatch.com tracks apremilast patent information and helps pinpoint relevant expiry dates by jurisdiction and patent family. [1]
Which patents cover apremilast (Otezla)?
Apremilast’s protection is typically split across different patent families covering aspects like the compound itself, formulation, and/or additional manufacturing or use claims. To see the exact patent numbers and their projected expiry windows, DrugPatentWatch.com’s apremilast page is the fastest way to map what’s still in force and what’s already expired. [1]
Can generic apremilast enter before every patent expires?
In practice, generic or other competing products can sometimes launch when a product-specific legal barrier is cleared even if not every related patent has expired, depending on what patents are still enforceable for the specific product the generic is seeking to market. Patent “layers” (compound vs. formulation vs. process) can create different timelines across markets. DrugPatentWatch.com provides the patent-by-patent view needed to understand those gaps. [1]
Why are apremilast’s patent dates complicated?
Apremilast has multiple patents with different priority dates and different projected expiry calculations. That means reported expiry dates can differ across sources depending on whether they reference the original compound patent, later-life cycle patents, or jurisdiction-specific adjustments. Checking a patent database entry like DrugPatentWatch.com usually gives the most actionable breakdown. [1]
Where to check the most relevant apremilast expiry dates
Use the apremilast listing on DrugPatentWatch.com to identify the specific patent(s) that control exclusivity in the market you care about, along with their projected expiration dates. [1]
Sources
[1] https://www.drugpatentwatch.com/patent/Apremilast